Important Safety Information You Should Know During IVF Treatment

During assisted reproductive treatments, some patients may hear the term Ovarian Hyperstimulation Syndrome (OHSS) and feel concerned. In fact, OHSS is a treatment-related complication that is preventable, monitorable, and usually manageable. Not every patient undergoing ovarian stimulation will experience it.

With careful treatment planning and close monitoring, the incidence and severity of OHSS have been significantly reduced in modern clinical practice. Below is a clear explanation of its causes, symptoms, and current prevention strategies in reproductive medicine.

What Is Ovarian Hyperstimulation Syndrome (OHSS)?

OHSS occurs during ovarian stimulation when the ovaries respond excessively to fertility medications. This causes temporary ovarian enlargement and the release of substances that increase blood vessel permeability. As a result, fluid may shift from the bloodstream into the abdominal or, less commonly, chest cavity, leading to discomfort.

Depending on timing, OHSS can be divided into two types:

· Early-onset OHSS: Usually occurs within one week after the trigger injection and is related to medication stimulation.

· Late-onset OHSS: Typically occurs after pregnancy, when rising hCG levels prolong or worsen symptoms.

Most cases are mild to moderate and improve with rest and monitoring. Only a small percentage progress to severe forms.

What Symptoms May Occur?

Common symptoms include:

· Abdominal bloating or discomfort

· Nausea and decreased appetite

· Rapid weight gain over a short period

· Reduced urine output

Doctors classify OHSS as mild, moderate, or severe based on symptoms, ultrasound findings, and blood test results to determine the appropriate care plan.

�� Reminder: Abdominal bloating does not necessarily indicate severe OHSS. Many symptoms are common responses after ovarian stimulation. Whether treatment is needed should always be determined by your physician.

Who Is at Higher Risk for OHSS?

Certain patients may have ovaries that are more sensitive to stimulation medications, including:

· Patients with polycystic ovary syndrome (PCOS)

· Younger women with good ovarian reserve

· Patients with a prior history of OHSS

· Those who develop a high number of follicles or experience rapidly rising hormone levels during stimulation

For these individuals, the medical team conducts risk assessments before treatment begins and adjusts stimulation protocols accordingly to ensure safety.

How Does Modern Reproductive Medicine Prevent OHSS?

Today, primary goal is prevention rather than treatment. Common strategies include:

· Individualized stimulation protocols: Medication doses are tailored based on age, ovarian condition, and hormone levels.

· Safer trigger methods: Choosing stimulation and trigger approaches that reduce the risk of excessive ovarian response.

· Freeze-all strategy: In high-risk cases, all embryos are frozen and fresh embryo transfer is postponed until the body has fully recovered.

· Close monitoring and timely adjustments: Regular follow-up visits during stimulation allow real-time protocol modifications if necessary.

Thanks to these strategies, severe OHSS has become relatively rare in modern fertility practice.

What If OHSS Occurs?

OHSS is usually temporary and gradually improves as ovarian activity decreases.

Mild to Moderate OHSS

· Rest at home and avoid strenuous activity

· Maintain adequate hydration and protein intake

· Monitor body weight, abdominal circumference, and urine output

· Attend follow-up visits or contact the medical team as instructed

Severe OHSS

· Hospitalization for close monitoring

· Intravenous fluids, fluid drainage, or other supportive treatments as needed

· Multidisciplinary or intensive care support in rare cases

Does OHSS Affect Future Pregnancy Success?

This is one of the most common concerns among patients.
In most cases, the answer is no.

Once symptoms have fully resolved, frozen embryo transfer can be performed. Pregnancy rates and live birth rates are comparable to standard treatment cycles, while ensuring maternal safety. Clinical experience and research show that with proper management, OHSS does not negatively affect long-term fertility outcomes.

A Reassuring Note

Ovarian hyperstimulation syndrome is a condition that reproductive specialists take very seriously and are well equipped to manage. Through comprehensive pre-treatment assessment, close monitoring during the cycle, and good communication between patients and healthcare providers, most cases can be handled safely.

If you experience significant abdominal bloating, abdominal pain, rapid weight gain, or decreased urine output during treatment, please contact your clinic promptly. We will evaluate and assist you in a timely manner, supporting you every step of your fertility journey.